05/20/2025
4:44 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
3:19 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/19/2025
4:49 PM | Centessa Pharmaceuticals (Issuer)
GOYAL ARJUN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
6:08 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
6:18 AM | Centessa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/12/2025
8:03 AM | Adage Capital Management, L.P. (Filed by)
Centessa Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
05/06/2025
8:00 AM | Centessa Pharmaceuticals (Filer)
Centessa Pharmaceuticals (Filer)
| Form DEF 14A | |
05/06/2025
8:03 AM | Centessa Pharmaceuticals (Filer)
| Form ARS | |
05/02/2025
3:17 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2025
3:58 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2025
3:09 PM | Centessa Pharmaceuticals (Subject)
HUSSAIN IQBAL J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for CNTA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Centessa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
04/25/2025
7:20 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2025
4:43 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2025
3:46 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/22/2025
3:59 PM | Centessa Pharmaceuticals (Filer)
| Form PRE 14A | |
04/21/2025
3:14 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/24/2025
6:31 AM | Centessa Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/24/2025
6:11 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2025
3:53 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:08 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2025
3:47 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
3:47 PM | Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
3:45 PM | Centessa Pharmaceuticals (Subject)
HUSSAIN IQBAL J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025
3:25 PM | Centessa Pharmaceuticals (Subject)
CHAO DAVID M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025
4:45 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
4:59 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:33 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
3:14 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/04/2025
3:55 PM | Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:55 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:55 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:56 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:56 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:56 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:57 PM | Centessa Pharmaceuticals (Issuer)
Kanes Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:57 PM | Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:08 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
3:04 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/28/2025
3:32 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:07 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
3:16 PM | Centessa Pharmaceuticals (Issuer)
Kanes Stephen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
July 2025 Rule Change to Impact Retirement Investors (Ad) There's a massive change from a new rule going into effect this July.
And it's one the Big Banks are already using to their advantage…
It allows them to treat this new asset like actual cash. Yes, Send Me My FREE Retirement Guide |
01/08/2025
6:00 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
3:30 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:31 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:32 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:32 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:33 PM | Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
4:28 PM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2024
5:10 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
4:22 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:18 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
4:09 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:10 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:11 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:02 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
3:14 PM | Centessa Pharmaceuticals (Subject)
HUSSAIN IQBAL J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024
4:03 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:14 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
3:03 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
3:07 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024
4:06 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
3:33 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
3:30 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
4:43 PM | Centessa Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
6:08 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
6:16 AM | Centessa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/25/2024
6:19 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
3:10 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
4:27 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
3:07 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
3:15 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:01 PM | Centessa Pharmaceuticals (Filer)
| Form 10-Q/A | |
09/27/2024
3:15 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:01 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
3:55 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
7:01 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
7:01 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:40 PM | Centessa Pharmaceuticals (Filer)
| Form 424B5 | |
09/11/2024
3:01 PM | Centessa Pharmaceuticals (Filer)
| Form S-3ASR | |
09/10/2024
3:04 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
3:06 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
6:08 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
4:06 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:12 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:13 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
3:19 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
4:15 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:32 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
3:13 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2024
3:38 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
3:52 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
How Trade Wars Are Creating Fresh Opportunities for Investors (Ad) Tariffs and trade tensions are back in the headlines, and while many are focused on the risks, smart investors know there’s also opportunity.
New supply chain shifts, pricing power adjustments, and sector revaluations are already underway—creating openings for those who act early.
That’s why we’ve just released our latest research:
📈 “From Tariffs to Returns: How to Capitalize on Trade Disputes in Your Portfolio” Position yourself ahead of the next move—get the full report here. |
08/13/2024
6:27 AM | Centessa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
6:15 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
3:30 PM | Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:31 PM | Bush Tia L (Reporting)
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:32 PM | Centessa Pharmaceuticals (Issuer)
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:30 PM | Centessa Pharmaceuticals (Issuer)
ZBAR BRETT I W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:31 PM | Centessa Pharmaceuticals (Issuer)
Stuckley Carol (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:32 PM | Centessa Pharmaceuticals (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:33 PM | Centessa Pharmaceuticals (Issuer)
Hukkelhoven Mathias (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
